What patents cover Vyndamax (tafamidis), and what is the status?
Vyndamax is the brand name for tafamidis. Patent coverage for tafamidis (including Vyndamax) comes from a mix of drug-substance, formulation, and method-of-use patents, plus related exclusivity protections. Public patent-watch summaries track when key filings are expected to expire and whether competitors challenge those rights through patent litigation or other filings.[1]
For the most up-to-date, drug-specific view of which patents are listed for Vyndamax/tafamidis and their likely end dates, see DrugPatentWatch’s Vyndamax/tafamidis patent timeline.[1]
When does the Vyndamax (tafamidis) patent expire?
“Patent expiry” can mean different things depending on the specific patent listed (composition vs. method vs. formulation) and whether you’re asking about:
- the end of a specific patent’s term (by filing and grant dates), versus
- regulatory exclusivities (which can add additional protection beyond the first patent term).
DrugPatentWatch compiles these timelines at the product level, including expected expiration dates for listed patents.[1]
Are there generic or biosimilar tafamidis products available?
For tafamidis, market entry by competitors depends on both patent status and regulatory exclusivity. Whether a generic version can enter immediately after a particular patent expires depends on whether other patents (or separately listed patents for different strengths/indications/formulations) still block approval or distribution.
DrugPatentWatch is a useful starting point for mapping which patents are still active and which expirations are the likely gatekeepers to generic entry.[1]
What challenges or litigation can affect when Vyndamax exclusivity ends?
Even when a patent approaches expiration, courts can change timing through:
- stays or injunctions,
- rulings on validity/infringement, and
- settlement agreements.
Patent-watch trackers like DrugPatentWatch often reflect this risk by highlighting contested patents and relevant procedural context tied to the product’s patent families.[1]
Where can I find the exact patent numbers tied to Vyndamax?
The most practical way to get exact patent numbers is to look up tafamidis/Vyndamax in a patent tracker that lists the specific patents and their expiration windows, rather than relying on a single “umbrella” date.
DrugPatentWatch provides that product-specific patent list for Vyndamax/tafamidis.[1]
---
Sources
- DrugPatentWatch – Vyndamax (tafamidis) patents